CBDA: The Raw Cannabinoid That Most Brands Destroy Before You Buy
← The Apothecary Journal

Cannabinoid Education

CBDA: The Raw Cannabinoid That Most Brands Destroy Before You Buy

By Divine Earth TheoryMarch 21, 20263 min read

The Compound That Disappears Before You Buy It

When hemp is growing in the field, it doesn't actually contain much CBD. What it contains is CBDA — cannabidiolic acid — the raw, unheated precursor from which CBD is derived.

CBDA is converted to CBD through decarboxylation: the application of heat causes a carboxyl group (COOH) to be released as carbon dioxide, transforming CBDA into the neutral cannabinoid CBD. This process happens naturally over time as hemp ages, and rapidly when hemp is heated — during extraction, processing, or consumption.

The result is that virtually every hemp extract product on the market contains CBD, not CBDA. The raw form has been converted — intentionally or as a byproduct of processing — before the product reaches you.

This matters because emerging research suggests CBDA may have distinct and potentially superior properties compared to its decarboxylated form.

What the Research Shows About CBDA

5-HT1A receptor affinity. CBDA has demonstrated significantly higher affinity for the serotonin 5-HT1A receptor than CBD in several studies. The 5-HT1A receptor is involved in anxiety regulation, mood, and nausea — and is the same receptor targeted by buspirone (an anti-anxiety medication) and certain antidepressants.

A 2013 study by Bolognini et al. in the British Journal of Pharmacology found that CBDA was more potent than CBD at the 5-HT1A receptor and produced stronger anti-nausea effects in animal models. A 2020 follow-up study found that CBDA reduced anticipatory nausea — the conditioned nausea response — at doses 1,000 times lower than CBD.

Enhanced bioavailability. Preliminary research suggests CBDA may be more bioavailable than CBD when taken orally. A 2020 study found that CBDA reached peak plasma concentrations faster and at higher levels than CBD in a comparative animal study. The mechanism is not fully understood but may relate to CBDA's greater water solubility compared to CBD.

COX-2 inhibition. CBDA has demonstrated inhibition of cyclooxygenase-2 (COX-2) — the same enzyme targeted by NSAIDs like ibuprofen. This suggests potential anti-inflammatory activity through a mechanism distinct from CBD's endocannabinoid system interactions.

Why Most Products Destroy CBDA

The reason CBDA is absent from most hemp products is simple: heat destroys it.

Most commercial hemp extraction methods involve significant heat exposure. CO2 extraction at elevated temperatures, ethanol extraction with post-processing evaporation, and distillation all apply enough heat to decarboxylate CBDA into CBD. This is often intentional — CBD is the compound that most consumers and brands are focused on, and decarboxylation increases CBD content.

But in destroying CBDA, these processes eliminate a compound with its own distinct pharmacological profile and potentially superior bioavailability.

Preserving CBDA: The Cold Extraction Advantage

Preserving meaningful CBDA content requires extraction methods that minimize heat exposure. Cold-process extraction — including our Full Cryosonic Extract™ method, which uses sub-zero temperatures — maintains CBDA in its native form alongside CBD and other cannabinoids.

The result is an extract that contains both CBDA and CBD, along with the full terpene profile and minor cannabinoids that are also preserved by low-temperature processing. This is a more complete representation of the hemp plant's actual chemistry than any heat-processed extract can provide.

The Bigger Picture: Raw vs. Processed Cannabinoids

The CBDA story is part of a broader principle: the less processing a hemp extract undergoes, the more of the plant's original chemistry is preserved. Heat, oxygen, and chemical solvents all degrade or transform the compounds that make hemp extract valuable.

This is why extraction method is one of the most important quality indicators for hemp products — and why brands that can speak specifically to their process (rather than just their CBD milligram count) are more likely to be delivering a genuinely superior product.


These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Learn about our Full Cryosonic Extract™ process →

CBDAcannabidiolic acidraw cannabinoidsdecarboxylationbioavailability5-HT1Anausea

Your Cart

0 items

Your cart is empty.

Add a formula to get started.

🍪

We use cookies

We use essential cookies to keep the site running and optional analytics cookies to understand how visitors use it. No personal data is sold. Privacy Policy

California residents: you have the right to opt out of the sale of personal information. Learn more